ClinConnect ClinConnect Logo
Search / Trial NCT04408170

Facilitating AcceLerated Clinical Validation Of Novel Diagnostics for COVID-19 (FALCON-C19)

Launched by MANCHESTER UNIVERSITY NHS FOUNDATION TRUST · May 28, 2020

Trial Information

Current as of July 21, 2025

Completed

Keywords

In Vitro Diagnostics Point Of Care Testing

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Work Stream A (in-hospital; Group 1 and Group 2):
  • Group 1 Inclusion Criteria:
  • We will include participants (patients or staff):
  • 1. That are 18 years or older
  • 2. That will require testing for COVID-19 in the opinion of the treating clinician
  • 3. That may have presented with acute symptoms of COVID-19 (e.g. fever, cough, dyspnoea, anosmia) or chest x-ray changes or they may be asymptomatic but require testing for other reasons
  • Group 2 Inclusion Criteria:
  • We will include participants:
  • 1. That are 18 years or older
  • 2. That have been admitted for another reason other than suspected SARS-CoV-2 infection, but when routinely swabbed they have been identified as positive for SARS-CoV-2 PCR
  • Work Stream B (Group 3):
  • We will include participants:
  • 1. That are 18 years or older
  • EITHER:
  • 2. They have been identified as positive for SARS-CoV-2 PCR through testing at national laboratory infrastructure OR
  • 3. They have been identified as negative for SARS-CoV-2 PCR through testing at national laboratory infrastructure
  • Work Stream C (Group 4):
  • We will include participants:
  • 1. That are 18 years or older
  • 2. Who are undergoing testing for COVID-19, whether they are symptomatic or symptomatic for COVID-19
  • Exclusion Criteria for all Work Streams:
  • 1. Patients where it is impossible/unsafe to obtain the required research samples
  • 2. Prisoners
  • 3. Patients where sampling is not feasible

About Manchester University Nhs Foundation Trust

Manchester University NHS Foundation Trust is a leading healthcare organization dedicated to delivering exceptional patient care and advancing medical research. As an integral part of the UK's National Health Service, the Trust encompasses a range of hospitals and services, fostering innovation in clinical research and trials. With a strong emphasis on collaboration and excellence, Manchester University NHS Foundation Trust is committed to improving health outcomes through rigorous scientific investigation and the translation of research findings into practice, ensuring that patients benefit from the latest advancements in medicine.

Locations

Nottingham, , United Kingdom

Stoke On Trent, , United Kingdom

Birmingham, , United Kingdom

Derby, , United Kingdom

Frimley, , United Kingdom

Keighley, , United Kingdom

Leeds, , United Kingdom

London, , United Kingdom

Manchester, , United Kingdom

Newcastle Upon Tyne, , United Kingdom

Oxford, , United Kingdom

Reading, , United Kingdom

Romford, , United Kingdom

Salford, , United Kingdom

Southampton, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Richard Body

Study Director

Manchester University NHS Foundation Trust

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials